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Association of accelerated 
dynamics of telomere sequence 
loss in peripheral blood leukocytes 
with incident knee osteoarthritis 
in Osteoarthritis Initiative cohort
Rebeca Guillén1,2, Fátima Otero1,2, Alejandro Mosquera1, María Vázquez‑Mosquera3, 
Ignacio Rego‑Pérez3, Francisco J. Blanco3,4,5* & José Luis Fernández1,2
Osteoarthritis (OA) is a chronic degenerative joint disease, being the main cause of laboral inability. 
Decreased telomere size in peripheral blood leukocytes (PBL) has been correlated with age‑related 
pathologies, like knee OA. In a dynamic approach, telomere‑qPCR was performed to evaluate the 
relative percentage of PBL telomere loss after a 6‑year follow‑up, in 281 subjects from the prospective 
osteoarthritis initiative (OAI) cohort. A radiological Kellgren‑Lawrence (KL) grade ≥ 2 was indicative 
of knee OA. Individuals with knee OA at recruitment (n = 144) showed a higher PBL telomere loss 
after 6 years than those without knee OA at baseline (n = 137; p = 0.018). Moreover, individuals that 
developed knee OA during the follow‑up (n = 39) exhibited a higher telomere loss compared to those 
that remained without OA (n = 98; p < 0.001). Logistic regression analysis showed that PBLs telomere 
loss was not significantly associated with knee OA at recruitment, but behaves as an independent 
risk factor associated with incidence after follow‑up (OR: 1.043; p = 0.041), together with maximum 
KL grade (OR: 3.627; p = 0.011), body mass index‑BMI (OR: 1.252; p < 0.001) and WOMAC‑index (OR: 
1.247; p = 0.021), at recruitment. The telomere decay in PBLs is faster in individuals with incident knee 
OA, possibly reflecting a systemic‑global accelerated aging that enhances the cartilage degeneration.
Abbreviations
BMI  Body mass index
KL  Kellgren–Lawrence
max-KL  Maximum KL grade
OA  Osteoarthritis
OAI  Osteoarthritis initiative
PBL  Peripheral blood leukocytes
qPCR  Quantitative PCR
T/S ratio  Average ratio of telomere repeat copy number to a single gene (36B4) copy number
WOMAC  Western Ontario and McMaster Universities Osteoarthritis Index
Osteoarthritis (OA) is the most common pathology of cartilage and joints, being a major cause of labor inability. 
Chondrocyte dysfunction possibly related to premature senescence leads to extracellular matrix degradation and 
local secretion of proinflammatory  cytokines1,2.
Telomeres are chromatin structures that cup the end of eukaryotic chromosomes. Human telomere DNA is 
constituted by a tandem array of the sequence 5’-TTA GGG -3’ and the complementary strand 5’-CCC TAA -3’. 
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Every time a cell replicates the DNA, 50–150 pb of terminal telomeric DNA sequence are lost, so the telomere is 
progressively shorter with aging, in somatic cells. If a critical size is achieved, replicative senescence is triggered, 
so the cell stops dividing and may die by  apoptosis3,4.
The telomere size from human peripheral blood leukocytes (PBL) decreases with aging. The length of tel-
omeres from leukocytes correlates with that from other somatic tissues from the same subject, independently of 
their proliferative  activity5,6. Telomere length evaluation has been found to be indicative of biological age and a 
potential predictor of lifespan in human  populations7. Furthermore, decreased PBL telomere size consistently 
correlated with increased risk of several common age related pathologies, like cardiovascular diseases, some 
cancer types, type II diabetes and  dementia4,8,9.
It has recently been demonstrated in individuals from the Osteoarthritis Initiative (OAI) consortium from 
USA that mean PBL telomere size at recruitment was an independent risk factor for concurrent knee OA, as well 
as radiological  severity10. Furthermore, this baseline PBL telomere length was associated with incident hand  OA11.
All the evaluations of PBL telomere size in OA studies were established at a single time-point. Nevertheless, 
telomere sequences decrease with time. The rates of decay in telomere dynamics could be more informative and 
relevant than single time-point determinations. The OAI consortium has been prospectively collecting accu-
rate and methodical data during several years of follow-up, including detailed clinical, imaging and analytical 
 parameters12. This OAI cohort is of choice to try to determine how PBL telomeres evolve in the same individual, 
in relation to OA.
Results
Cohorts characteristics. 281 individuals (152 women) of Caucasian ancestry were eligible for the study 
based on availability of both baseline and 72-month radiographs and baseline PBL telomere length data. Mean 
age was 58.48 ± 7.27 years. Among the 281 individuals at baseline, 144 met the definition for prevalent knee OA 
and 137 for non-prevalent (without knee OA). After 6 years of follow-up, those prevalent at baseline continued 
with knee OA, as is obvious. On the other hand, focusing on those non-prevalent at baseline, after 6 years of 
follow-up, 39 developed knee OA (incident) whereas 98 continued without knee OA (non-incident) (Table 1).
Prevalent radiographic knee OA. Individuals with prevalent knee OA at recruitment (max-KL ≥ 2; 
n = 144) showed a significant higher relative percentage of PBL telomere loss after 6 years than those without 
radiographic knee OA at baseline (max-KL < 2; n = 137; median: 35.05 vs 30.44, p = 0.018) (Table 2A). Moreover, 
PBL telomere shortening tended to be faster in males compared to females (p = 0.094). No significant differences 
were observed between individuals with or without hypertension (p = 0.318) (Table 2A). A positive correlation 
was found between PBL telomere loss and BMI (p = 0.010) (Table 2B). The correlation between age and PBL 
telomere decay was near the limit of statistical significance (p = 0.091) (Table 2B).
Multivariable analysis by binary logistic regression analysis did not reveal any significant association of age, 
hypertension and dynamics of PBL telomere loss with prevalent knee OA (Table 3A). Yet, BMI (OR: 1.071; 
p = 0.042), gender (male; OR: 0.577; p = 0.048) and Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) (OR: 1.273; p < 0.001) manifested as risk factors significantly associated with prevalent knee 
OA (Table 3A). The three previously identified significant variables, BMI, gender and WOMAC-index, were 
introduced in the logistic regression model, maintaining their significance (Table 3B).
Incident radiographic knee OA. Regarding incident knee OA, those individuals that developed radio-
graphic knee OA during the 6 years of follow-up period (n = 39), exhibited a higher relative percentage of PBL 
telomere loss in comparison to those that remained without knee OA (n = 98; median: 41.36 vs 26.25, p < 0.001). 
However, their magnitude of dynamic loss was not significantly different from that of patients with prevalent 
knee OA (median: 41.36 vs 35.05 p = 0.142) (Fig. 1).
Table 1.  Characteristics of the cohorts.
Non-incident (n = 98) Incident (n = 39) Prevalent (n = 144) Total (n = 281)
Age (mean ± SD) 56.85 ± 7.52 59.03 ± 6.97 59.44 ± 7.04 58.48 ± 7.27
Gender (n (%))
Female 60 (61.22) 26 (66.67) 66 (45.83) 152 (54.09)
Male 38 (38.78) 13 (33.33) 78 (54.17) 129 (45.91)
BMI (mean ± SD) 25.00 ± 3.54 29.66 ± 4.28 29.05 ± 4.35 27.72 ± 4.53
Hypertension (n (%))
Yes 19 (19.39) 9 (23.08) 45 (31.25) 73 (25.98)
No 79 (80.61) 30 (76.92) 99 (68.75) 208 (74.02)
Baseline max-KL (n (%))
0 69 (70.41) 11 (28.21) 0 (0.00) 80 (28.48)
1 29 (29.59) 28 (71.79) 0 (0.00) 57 (20.28)
2 0 (0.00) 0 (0.00) 78 (54.17) 78 (27.76)
3 0 (0.00) 0 (0.00) 48 (33.33) 48 (17.07)
4 0 (0.00) 0 (0.00) 18 (12.50) 18 (6.41)
% PBL telomere loss (mean ± SD) 27.70 ± 13.25 38.51 ± 9.33 34.37 ± 11.61 32.62 ± 12.50
WOMAC (mean ± SD) 0.95 ± 2.29 3.52 ± 3.41 9.94 ± 5.99 3.86 ± 5.19
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Table 2.  Evaluation of the relative percentage of telomere loss after 6 years of follow-up, in peripheral blood 
leukocytes from individuals from the OAI cohort, in relation to parameters obtained at recruitment. (A) 
Comparisons performed by Mann–Whitney U-test. (B) Correlation analysis.
n Mean 95% CI Median P
(A)
Gender
Male 129 33.98 31.68–36.29 35.76
0.094
Female 152 31.47 29.58–33.35 31.82
Hypertension
Non-hypertension 208 32.21 30.54–33.89 32.10
0.318
Hypertension 73 33.78 30.72–36.85 35.24
Baseline max-KL grade
KL < 2 137 30.78 28.55–33.00 30.44
0.018
KL ≥ 2 144 34.37 32.46–36.29 35.05
(B)
Age (years)
Spearman’s Rank Correlation Coefficient
0.091 (r = 0.101)
BMI (Kg/m2) 0.010 (r = 0.153)
Table 3.  Prevalent and incident radiographic knee OA: (A) Multivariable analysis using logistic regression 
analysis to evaluate the association of variables with prevalent and incident knee osteoarthritis. (B) Logistic 
regression model with selected variables. Significance was defined as p < 0.05.
Prevalent Incident
OR 95% CI P OR 95% CI P
(A)
Age (years) 1.030 0.991–1.070 0.134 1.041 0.971–1.115 0.257
Baseline max-KL grade – – – 3.988 1.420–11.196 0.009
BMI (Kg/m2) 1.071 1.002–1.144 0.042 1.266 1.115–1.437  < 0.001
Gender (Male) 0.577 0.334–0.995 0.048 2.534 0.872–7.364 0.088
Hypertension 1.397 0.746–2.616 0.296 0.518 0.144–1.858 0.313
% PBL telomere loss 1.011 0.989–1.034 0.313 1.047 1.002–1.094 0.039
WOMAC 1.273 1.162–1.395  < 0.001 1.286 1.065–1.552 0.009
(B)
Baseline max-KL grade – – – 3.627 1.342–9.800 0.011
BMI (Kg/m2) 1.082 1.013–1.155 0.019 1.252 1.106–1.417  < 0.001
Gender (Male) 0.558 0.325–0.956 0.034 – – –
% PBL telomere loss – – – 1.043 1.002–1.087 0.041
WOMAC 1.280 1.164–1.396  < 0.001 1.247 1.034–1.505 0.021
Figure 1.  Rate of PBL telomere loss in prevalent, incident and non-incident knee OA. Kruskal–Wallis test 
evidenced significant differences among the three groups (p < 0.001). Incident knee OA exhibited a higher 
relative fraction of PBL telomere loss in comparison to non-incident OA (mean: 38.51 vs 27.70, Mann–Whitney 
U-test, p < 0.001). Magnitude of dynamic loss was not significantly different between patients with incident and 
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Binary logistic regression analysis evidenced that the dynamics of PBL telomere loss was a significant associ-
ated risk factor of incidence of knee OA (OR: 1.047; p = 0.039), as well as BMI (OR: 1.266; p < 0.001), WOMAC 
(OR: 1.286; p = 0.009) and max-KL grade (OR: 3.988; p = 0.009), at baseline (Table 3A). Age, gender and hyper-
tension were not found to be significantly associated. Under the logistic regression model including the four 
variables previously recognized as significant, PBL telomere decay remained significantly associated with incident 
knee OA (OR: 1.043; p = 0.041) (Table 3B).
Discussion
Assessment of telomeres in PBL provides knowledge about how systemic biological aging is progressing and 
subsequently may indicate how the articular senescence level is evolving. The present study intended to perform 
the first evaluation of the dynamics of telomere decay in each individual of the selected cohort. This is a more 
stringent assessment than the single-time point evaluation and confidently confirms a higher velocity of PBL 
telomere loss in individuals with prevalent and with incident knee OA.
Although PBL telomere size may be associated with many parameters related to aging and health status, 
multivariable analysis using logistic regression analysis had evidenced PBL telomere size at recruitment as a risk 
factor significantly associated to the prevalence of knee OA at  baseline10. Regarding hand OA, the association of 
PBL telomere amount at recruitment with prevalent hand OA lost significance in the model adjusted for age, sex 
and BMI, whereas the association was evidenced for incident hand  OA11. The results of our dynamic telomere 
approach were close to those from the single-time point evaluation at baseline regarding hand OA. In fact, the 
relative percentage of PBL telomere decay did not reach statistical significance as an independent risk factor for 
prevalent knee OA, whereas it was a significantly associated risk marker of incident knee OA.
It seems paradoxical that the single-time determination of PBL telomeres at recruitment was significantly 
associated with concurrent knee OA, whereas the dynamic telomere decay did not. Nevertheless, despite the 
relative percentage of PBL telomere loss in our group of individuals with prevalent knee OA, it was lower than 
that compared to incident OA, it was higher in comparison with non-incident subjects, although not reaching 
statistical significance. A relative highly accelerated PBL telomere decay may indicate a rapid progression of bio-
logical aging at the systemic level, which locally, at the joint cartilage, may be related to accelerated chondrocyte 
senescence and subsequent development of knee OA, i.e. incidence. Once the illness is established, the telomeres 
would be eroded at a lower rate. In fact, the standard PBL telomere decay is not homogeneous throughout life, 
being more intense during initial years and slowing slightly with  aging13. Since biological aging may be acceler-
ated in OA, the progressive slowing kinetics could be shifted to earlier chronological ages.
Overall, knee OA is mainly developed in the group of subjects with a higher PBL telomere loss over time, i.e. 
with an accelerated biological aging  phenotype14. This unfavourable physiological background would enhance 
chondrocyte senescence, decreasing the cartilage resistance to other mechanic, metabolic, inflammatory or 
oxidative  stressors15. Some of these stressors may be in connection with risk factors evidenced in the logistic 
regression analysis, like BMI, which may be linked to obesity. The confluence of all these factors would contribute 
to the appearance and progression of the articular destruction. This was a retrospective cohort study, limited to a 
subset of Caucasian subjects and results support a further validation using prospective cohorts. In addition, the 
sample size of individuals with incident knee OA is not very high, but necessarily related to the natural evolution 
of the pathology itself after the selection of healthy individuals.
Patients and methods
Subjects. To study the association between radiographic knee OA and telomere length we conducted a 
cross-sectional and longitudinal analysis of data from a subset of participants in the Osteoarthritis Initiative 
(OAI). The OAI is a multicenter cohort study of 4,796 adults with or at risk for symptomatic knee OA. Four clini-
cal sites (Memorial Hospital of Rhode Island, The Ohio State University, University of Maryland and Johns Hop-
kins University, and the University of Pittsburgh) recruited participants between February 2004 and May 2006. 
Three subcohorts are identified; Progression subcohort, Incidence subcohort, and Non-exposed control subco-
hort. OAI data and protocols are available for free public  access12. This retrospective cohort study study includes 
281 Caucasian individuals (129 male and 152 female) with an age range of 45–78 years (mean 58.48). Subjects 
included in the study were those whose telomere had already been quantified at baseline and whose results 
were already published in previous  studies10,11. A subset was eligible based on availability of both baseline and 
72-month radiographs and baseline PBL telomere length data. The OAI study was approved by the institutional 
review boards at each OAI clinical site and the coordinating center (University of California, San Francisco) and 
informed consent was obtained from the participants. This study was also approved by the local Galician Ethics 
Committee (Comité Autonómico de Ética da Investigación de Galicia) with registry code 2018/129.
Evaluation of knee OA. X-ray images from both knees were considered in each individual, being evalu-
ated according to the Kellgren-Lawrence (KL) score. KL grade was established for each knee, including patel-
lofemoral and tibiofemoral joints. The KL grade assigned to the subject was the maximum obtained from the 
evaluation of the two knees, i. e. max-KL grade. Prevalent radiographic knee OA was defined when an individual 
had a maximum KL grade (max-KL) ≥ 2 considering both knees (n = 144), at recruitment. Incident knee OA was 
defined when max-KL grade increased from < 2 at recruitment to ≥ 2 after 72-month follow-up (n = 39). Non-
incident knee OA was defined as max-KL grade maintained < 2 after the 72-month follow-up (n = 98).
Evaluation of telomere sequences. DNA from PBL was extracted from the blood sample obtained at 
recruitment and after a 6-year follow-up. Coded DNA samples were processed by research personnel blinded to 
the status of the subjects. The average telomere amount in PBL was measured with a standard validated quanti-
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tative PCR (qPCR) based assay as  described16. This method measures the average ratio of telomere repeat copy 
number to a single gene (36B4) copy number (T/S ratio) in each sample. The technique was performed using a 
LightCycler thermocycler (LightCycler 480, Roche Diagnostics, Werk Penzberg, Germany). DNA samples were 
amplified in parallel 20 μl PCR reactions that contained 10 ng of sample DNA, the DNA master SYBR Green I 
kit (LightCycler 480 Sybr Green I Master, Roche Diagnostics) and 500 nM of primers for the telomere (forward: 
5′ CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT 3′; reverse 5′ GGC TTG CCT TAC CCT TAC 
CCT TAC CCT TAC CCT TAC CCT 3′) and for the 36B4 (forward: 5′ CAG CAA GTG GGA AGG TGT AATCC 3′; 
reverse: 5′ CCC ATT CTA TCA TCA ACG GGT ACA A 3′). To avoid possible inter-assay variability, the paired sam-
ples of each subject, at recruitment and after 6 years, were processed in the same plate of PCR, each in quadru-
plicate. The average efficiency was 1.8 for telomeric amplification and 1.9 for 36B4 amplification. The T/S ratio 
was calculated using these efficiency values: T/S ratio =  efficiency−CqTel/efficiency−Cq 36B4. The relative percentage 
of telomere loss in each individual was defined as [(T/S ratio at recruitment − T/S ratio after 72 months) / T/S 
ratio at recruitment] × 100.
Statistical analysis. Caucasian individuals (n = 281) were included in this study. This sample size allowed 
us to estimate a difference of 9% and 5% in the relative loss of telomere between the incident and non-incident 
population and, prevalent vs non-prevalent, respectively, with a safety of 95% and a statistical power of 90%.
Descriptive analysis was performed for all variables studied. Continuous variables were reported using 
means ± standard deviations (SD). For dichotomous/categorical variables, absolute numbers and percentages 
were computed.
Relative percentage of PBL telomere loss after 6 years was analyzed according to patients’ characteristics as 
gender, hypertension and baseline max-KL grade, using the Mann–Whitney and Kruskall-Wallis test. For age 
and BMI, the Spearman’s Rank Correlation Coefficient was performed.
A univariate and multivariable logistic regression analysis were performed to identify the variables indepen-
dently related with prevalent and incident radiographic knee OA.
A multivariable logistic regression analysis was performed to determine the relative percentage of PBL asso-
ciation with incident OA, adjusting for gender, BMI and WOMAC as potential confounders. Odds Ratios and 
their 95% confidence intervals (CI) were expressed.
All of the tests were carried out bilaterally, considering values of p < 0,05 as significant. Data were analyzed 
using SPSS software version 20 (Chicago, Illinois, USA).
Ethics approval and consent to participate. The OAI study was approved by the institutional review 
boards at each OAI clinical site and the coordinating center (University of California, San Francisco) and 
informed consent was obtained from the participants. This study was also approved by the local Galician Ethics 
Committee (Comité Autonómico de Ética da Investigación de Galicia) with registry code 2018/129. All research 
was performed in accordance with relevant guidelines/regulations and with the Declaration of Helsinki.
Consent for publication. Non applicable.
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